EUVIMEDEUVIMED entdecken
BeobachtungsstudieKohortenstudieOpen Access · CC BY 4.0

Red cell distribution width and mean platelet volume as mortality markers in patients with COVID-19: a retrospective cohort study

Jehat Kiliç, Ömer F Alakuş, İhsan Solmaz

The Journal of Infection in Developing Countries · 28.02.2026 · 20 (02) · 160-166

DOI: 10.3855/jidc.21878 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The Journal of Infection in Developing Countries, online erschienen am 28.02.2026. Verfasst von Jehat Kiliç und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Health Sciences, Gazi Yasargil Training and Research Hospital, Department of Internal Medicine, Diyarbakir, Turkey. Hauptthemen laut MEDLINE: COVID-19, Mean Platelet Volume, Erythrocyte Indices. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This study investigates RDW and MPV as simple, cost-effective markers linked to increased mortality in COVID-19, highlighting their potential prognostic value in viral infections.

Methods

This retrospective observational study examined hospitalized COVID-19 patients from 2020 to 2022, assessing clinical outcomes such as ICU admission, hospital stay duration, and mortality. It focused on the prognostic value of Red Cell Distribution Width (RDW) and Mean Platelet Volume (MPV), investigating whether elevated levels of these markers could serve as accessible indicators of mortality risk.

Results

The mean age at diagnosis among patients was 48.07 ± 17.33 years. The mean hospital stay was 5.82 ± 5.44 days. Among 1,810 patients, elevated Red Cell Distribution Width (RDW > 15%) and Mean Platelet Volume (MPV > 11.5 fL) were associated with significantly higher mortality rates (p < 0.01 and p = 0.014, respectively). Logistic regression analysis identified age, male sex, length of hospital stay, WBC count, RDW-CV, glucose, ferritin, and low albumin as independent predictors of mortality. Conversely, MPV, D-dimer, creatinine, calcium, and ALT were not significant mortality predictors. These findings suggest that routine markers, particularly RDW and WBC, may serve as accessible and cost-effective tools for early risk stratification in COVID-19 patients, while others, like MPV, may have limited independent prognostic value in this context.

Conclusions

RDW and MPV, routinely available from blood tests, may help identify early clinical deterioration, supporting timely interventions to improve outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Mean Platelet VolumeErythrocyte IndicesHumansRetrospective StudiesMaleFemaleBiomarkersMiddle AgedPrognosisAdultAgedSARS-CoV-2Length of Stay

Stichwörter der Autor:innen

COVID-19mean platelet volumered cell distribution widthviral infection

Substanzen

Biomarkers

Autor:innen und Institutionen

  • University of Health Sciences, Gazi Yasargil Training and Research Hospital, Department of Internal Medicine, Diyarbakir, Turkey .

Zitieren

APA

Kiliç, J., Alakuş, Ö. F., & Solmaz, İ. (2026). Red cell distribution width and mean platelet volume as mortality markers in patients with COVID-19: a retrospective cohort study. The Journal of Infection in Developing Countries, 20(02), 160-166. https://doi.org/10.3855/jidc.21878

Vancouver

Kiliç J, Alakuş ÖF, Solmaz İ. Red cell distribution width and mean platelet volume as mortality markers in patients with COVID-19: a retrospective cohort study. The Journal of Infection in Developing Countries. 2026;20(02):160-166. doi:10.3855/jidc.21878

BibTeX
@article{Kili2026,
  author = {Kiliç, Jehat and Alakuş, Ömer F and Solmaz, İhsan},
  title = {Red cell distribution width and mean platelet volume as mortality markers in patients with COVID-19: a retrospective cohort study},
  journal = {The Journal of Infection in Developing Countries},
  year = {2026},
  volume = {20},
  number = {02},
  pages = {160--166},
  doi = {10.3855/jidc.21878}
}
Kostenlos starten →